Literature DB >> 3558116

Cefodizime, an aminothiazolylcephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series.

J Blumbach, W Dürckheimer, E Ehlers, K Fleischmann, N Klesel, M Limbert, B Mencke, J Reden, K H Scheunemann, E Schrinner.   

Abstract

The synthesis as well as in vitro antibacterial activity and pharmacokinetic behavior of cefodizime (HR 221, 1a), its analogs and derivatives is described. In this comparison, cefodizime stands out for its balance between its high antibacterial activity, prolonged elimination half-life and high AUC in mice and dogs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558116     DOI: 10.7164/antibiotics.40.29

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  In vivo activity of cefodizime.

Authors:  P M Shah; H Knothe
Journal:  Infection       Date:  1992       Impact factor: 3.553

Review 2.  Pharmacokinetic profile of cefodizime.

Authors:  D Brockmeier; E E Dagrosa
Journal:  Infection       Date:  1992       Impact factor: 3.553

Review 3.  In vitro activity of cefodizime.

Authors:  H Knothe; P M Shah
Journal:  Infection       Date:  1992       Impact factor: 3.553

4.  Hemostasis in patients with normal and impaired renal function under treatment with cefodizime.

Authors:  K Andrassy; J Koderisch; D Trenk; E Jähnchen; A Iwand
Journal:  Infection       Date:  1987       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.